Summary

This article provides insights into multiple therapies and treatments for lymphoma. Specific discussions include role of radiotherapy (RT) for the treatment of Hodgkin lymphoma, the RAPID [NCT00282035] trial, the predictive values of positron emission tomography (PET), an update on maintenance therapy in hematological malignancies, the PRIMA [NCT00140582] trial, as well as the use of Fluorodeoxyglucose-PET for the diagnosis, restaging, and follow-up in patients with lymphoma.